You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • AB0281 Remission rates during golimumab treatment for rheumatoid arthritis are associated with differences in baseline disease states across geographic regions in the go-more study

Citation Tools

Article menu
Download PDFPDF
Abstracts accepted for publication
Rheumatoid arthritis - anti-TNF therapy
AB0281 Remission rates during golimumab treatment for rheumatoid arthritis are associated with differences in baseline disease states across geographic regions in the go-more study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Durez P, Pavelka K, Lazaro M, et al
AB0281 Remission rates during golimumab treatment for rheumatoid arthritis are associated with differences in baseline disease states across geographic regions in the go-more study
Annals of the Rheumatic Diseases 2013;72:A872.